aTyr Pharma (NASDAQ:ATYR) Lowered to Hold Rating by Leerink Partnrs
aTyr Pharma (NASDAQ:ATYR – Get Free Report) was downgraded by equities research analysts at Leerink Partnrs from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports. Other equities research analysts have also issued research reports about the stock. Wall Street Zen lowered shares of aTyr Pharma from […]
More Stories
DOJ Sues California After Flagging 20,000 ‘Likely Noncitizens’ Registered to Vote
By Jill McLaughlin The Department of Justice (DOJ) filed a lawsuit against California on Oct. 15 over its voter list...
Ukraine Resumes Strikes on Russian Refineries as Zelenskyy Says ‘We’re Done’ With Trump’s Energy Truce
By Guy Birchall Ukraine has resumed attacks on Russian refineries after Ukrainian President Volodymyr Zelenskyy said Kyiv was “done” complying...
Musk Says US Government Is Controlling Starshield Services Amid Reported Disruptions in Ukraine
By Ryan Morgan SpaceX CEO Elon Musk denied reports that the company curbed its military-oriented Starshield satellite internet service in...
2027 Social Security Payment Boost Announced: 4 Things to Know
By Jack Phillips Social Security officials on Wednesday announced the largest cost-of-living adjustment (COLA) for retired beneficiaries in four years,...
IEA to Accelerate Emergency Release of 100 Million Barrels of Oil
By Jack Phillips The International Energy Agency (IEA) has announced that its member nations will hasten the release of emergency...
US Producer Inflation Posts Sharpest Monthly Gain Since 2022
By Andrew Moran U.S. producer inflation posted its sharpest monthly increase since Russia’s invasion of Ukraine in March 2022, new...